BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14534540)

  • 1. Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.
    Starczynowski DT; Reynolds JG; Gilmore TD
    Oncogene; 2003 Oct; 22(44):6928-36. PubMed ID: 14534540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
    Starczynowski DT; Reynolds JG; Gilmore TD
    Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
    Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
    Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Envelope-dependent transactivation by the retroviral oncoprotein v-Rel is required for efficient malignant transformation of chicken spleen cells.
    Epinat JC; Dvorin EL; Gilmore TD
    Oncogene; 2000 Jun; 19(28):3131-7. PubMed ID: 10918567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes.
    Fan Y; Rayet B; Gélinas C
    Oncogene; 2004 Feb; 23(5):1030-42. PubMed ID: 14647412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.
    Fan Y; Gélinas C
    Oncogene; 2007 Jun; 26(27):4038-43. PubMed ID: 17173064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
    Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
    Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chicken c-Rel-estrogen receptor chimeric protein shows conditional nuclear localization, DNA binding, transformation and transcriptional activation.
    Zurovec M; Petrenko O; Roll R; Enrietto PJ
    Oncogene; 1998 Jun; 16(24):3133-42. PubMed ID: 9671392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
    Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
    Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation of gene expression by nuclear and cytoplasmic rel proteins.
    Hannink M; Temin HM
    Mol Cell Biol; 1989 Oct; 9(10):4323-36. PubMed ID: 2555689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three mutations in v-Rel render it resistant to cleavage by cell-death protease caspase-3.
    Barkett M; Dooher JE; Lemonnier L; Simmons L; Scarpati JN; Wang Y; Gilmore TD
    Biochim Biophys Acta; 2001 Apr; 1526(1):25-36. PubMed ID: 11287119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for assessing the in vitro transforming activity of NF-κB transcription factor c-Rel and related proteins.
    Gilmore TD; Gélinas C
    Methods Mol Biol; 2015; 1280():427-46. PubMed ID: 25736765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a human REL-estrogen receptor fusion protein with a reverse conditional transforming activity in chicken spleen cells.
    Kalaitzidis D; Ok J; Sulak L; Starczynowski DT; Gilmore TD
    Oncogene; 2004 Sep; 23(45):7580-7. PubMed ID: 15326488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site.
    Capobianco AJ; Gilmore TD
    Oncogene; 1991 Dec; 6(12):2203-10. PubMed ID: 1766669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain.
    Sarkar S; Gilmore TD
    Oncogene; 1993 Aug; 8(8):2245-52. PubMed ID: 8336947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells.
    Gilmore TD; Temin HM
    J Virol; 1988 Mar; 62(3):703-14. PubMed ID: 2828665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts.
    Capobianco AJ; Simmons DL; Gilmore TD
    Oncogene; 1990 Mar; 5(3):257-65. PubMed ID: 2179815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids.
    Kralova J; Schatzle JD; Bargmann W; Bose HR
    J Virol; 1994 Apr; 68(4):2073-83. PubMed ID: 8138992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.
    Morrison LE; Boehmelt G; Enrietto PJ
    Oncogene; 1992 Jun; 7(6):1137-47. PubMed ID: 1594245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel.
    Mosialos G; Hamer P; Capobianco AJ; Laursen RA; Gilmore TD
    Mol Cell Biol; 1991 Dec; 11(12):5867-77. PubMed ID: 1944267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.